Independent Review Committee

in page functions
 

Gavi has established an Independent Review Committee for the review of new proposals

To support an independent and systematic process of reviewing new proposals, Gavi has established an Independent Review Committee (IRC).

Key characteristics

Since its inception, the structure and composition of the Gavi IRC have been considered effective due to key characteristics:

  • the committee relies upon a wide range of experts in public health, epidemiology, development, finance and economics;
  • the committee is based on a system of peer review; and
  • the committee is independent.

The Gavi Board

The IRC is directly accountable to the Gavi Board and communicates its recommendations to the Gavi Board. The Gavi Board makes the ultimate decision on whether to approve the funding of new country grants. The Gavi Board also has the responsibility for communicating its decision to countries, via the Gavi Secretariat.

More on this topic

The Independent Review Committee reviews new proposals and makes recommendations to the Gavi Board

The mandate of the new proposals IRC is to review each application for all types of new support, to enable a more holistic view of the broad portfolio of support Gavi provides to countries, rather than looking at each new application in isolation from the others, and to make recommendations to the Gavi Board.

This review should consider the information available to countries within current guidelines and application forms and ensure that any new proposal contributes to achieving:

  • the Gavi mission - ‘To save children’s lives and protect people’s health by increasing access to immunisation in poor countries’;
  • the Gavi's strategic goals; and
  • the eligibility criteria as per Gavi guidelines for new proposals of support.

Members of the Independent Review Committee consist of specialists from a broad range of expertise

IRC members generally serve a term of three years. This term may be renewed for another period of up to 3 years. Upon reaching the second term limit IRC members will not be eligible to serve on the IRC for at least 1 year. During their term IRC members may be called upon to serve on the IRC for review of country plans or requests for extensions for which he or she has specific relevant skills.

Range of expertise

The increasing complexity of new proposals and the subsequent grant monitoring requires an IRC with a broad range of expertise in areas such as:

  • Routine immunisation programmes, especially at country level;
  • Management of campaigns;
  • Delivery of health services including child and adolescent health;
  • Health systems strengthening and management;
  • Epidemiology and disease control;
  • Cold chain and logistics;
  • Financial and budget analysis; and
  • Gender and equity.

The IRC should also consist of technical experts knowledgeable on the developing country context and relevant issues, including in a variety of fields related to immunisation and health systems, and who have practical experience working in or with developing country governments, civil society, and other partners in those contexts. In addition, the IRC should be geographically diverse, with a male and female representation consistent with Gavi’s Gender Policy and Guidelines on the Gavi Board Gender Balance.

Each IRC member is asked to sign a confidentiality and conflict of interest statement and will not come from Vaccine Alliance partner agencies, and have not taken part in technical assistance to or pre-review processes of country applications.

List of IRC pool members

Click here to view the biographies of the IRC members  

Nr

Name

Areas of expertise

Current position

1

Sam Agbo

Health systems management, immunisation programs, and civil society

Head of Health & HIV at Save the Children

2

Emmanuel Addo-Yobo

child health; clinical paediatrics; surveillance for rotavirus and congenital rubella syndrome

Professor of Child Health at the School of Medical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Ghana

3

Salah Al Awaidy

Vaccine-preventable diseases programming, immunisation and cold chain

Advisor at the Ministry of Health, Oman

4

Badel Al Rawani

Vaccines management and cold chain

Head of the Expanded Programme on Immunisation in the Department of Communicable Disease Surveillance and Control, Ministry of Health, Oman

5

Roland Georges Amehou

Health economics and financial and budget analysis

Health economist in developing countries

6

Rafah Salam Aziz

MNCH programme management, immunisation

Independent consultant

7

Annette Bongiovanni

Programme management, monitoring and evaluation, and operations research

Principal at International and Business Technical Consultants, Inc, United States

8

Gabriel Carrasquilla

Epidemiology

Founder and Director of ASIESALUD

9

John Clements

Routine immunisation services in developing countries

Independent consultant and Associate Professor in the School of Population Health, Faculty of Medicine and Dentistry, University of Melbourne, Honorary Associate Professor at Monash University

10

Chris Coulter

Gender, human rights, good governance and Results Based Methodology

Director of Programs, senior consultant at Indevelop Sweden

11

Dora Curry

CSOs, data systems at community and primary care level, data utilization for program improvement

Senior Technical Advisor for Monitoring and Evaluation in CARE-USA’s Sexual, Reproductive and Maternal Health team

12

Ahmed Ali Darwish

Epidemiology and immunisation programs

Independent consultant

13

Jean Marie Edengue Ekani

Immunisation, health systems management, epidemiology

Immunisation specialist MoH, Cameroon

14

Linda Eckert

Vaccines, especially in the intersection of immunisation with reproductive health

Professor in Obstetrics and Gynecology and Adjunct Professor in the Department of Global Health at the University of Washington in Seattle

15

George Gotsadze

Health policy and systems, health care financing

Director of the Curatio International Foundation in Georgia. Professor of health care financing and health policy at the School of Public Health, Tbilisi State Medical University Georgia

16

Ulla Kou Griffiths

Economics of vaccines, economic evaluations of new vaccines

Lecturer in Health Economics in the Department of Global Health and Development at the London School of Hygiene and Tropical Medicine (LSHTM)

17

John Grundy

Health systems strengthening and immunisation

Independent consultant

18

Terence Hart

Supply chain logistics and technologies

Independent consultant

19

Philippe Jaillard

vaccine delivery, cold chain equipment management, injection safety and waste management, logistics training program development

Program Director: Technologies and Health Logistics, project coordinator of LOGIVAC

20

Miloud Kaddar

Health economics, economics of vaccines and immunization, health system development and financing

Independent consultant

21

Elsie Le Franc

Health systems and health policy analysis

Professor Emeritus and Adjunct Professorial Research Fellow, University of the West Indies, Jamaica

22

Marina Madeo

Health systems strengthening, technical coordination, health sector governance

Independent consultant

23

Marty Makinen

Health economics, immunisation

Principal and Managing Director of Results for Development Institute (R4D) in Washington, DC

24

Kapil Maithal

Conceptualizing, managing, strategizing and execution of development of vaccines for global use; vaccine advocacy and preparedness

General Manager and Head-Research and Development at Indian Immunologicals Limited (IIL), Hyderabad, India

25

Andrew McKenzie

Health systems strengthening, health planning and management

Independent consultant, Senior Partner in Health Partners International

26

Sandra Mounier-Jack

Health policy and health financing

Lecturer in Health Policy at the Faculty of Public Health and Policy of the London School of Hygiene and Tropical Medicine

27

Amani Mustafa

Immunisation, new vaccines, campaign management, cold chain and health system planning and monitoring.

Public Health Training Initiative Project Manager, The Carter Center, Sudan. National Director of Planning, Monitoring, and Policy Directorate, National Medicines and Poisons Board, Sudan

28

Maryanne Neill

Health information systems, cold chain logistics, immunisation coverage estimation.

Independent consultant

29

Frank Nyonator

Health systems and health service provision

Ag. Dean of the School of Public Health, University of Health and Allied Sciences (UHAS) Ghana, Head of the Health Policy, Planning and Management Department of the School

30

Peju Olukoya

Gender, women and health; sexual and reproductive health; health systems

Independent consultant

31

Michel Otepa

Immunisation and disease control

Senior Immunisation Technical Officer, Maternal Child Health Integrated Program (MCHIP), Washington, DC

32

Bolanle Oyeledun

Health systems strengthening, MNCH, immunisation

Chief Executive Officer at Centre for Integrated Health Programs (CIHP), Nigeria

33

Koye Oyerinde

Paediatrics, Health Systems Strengthening

Attending paediatrician in private practice

34

Zeenat Patel

Public health, epidemiology, immunisation

Independent consultant

35

Arletty Pinel

Health systems strengthening, maternal health

Independent consultant

36

Bob Pond

health systems strengthening with special emphasis on child health, disease control and HIS development

Independent consultant

37

Kshem Prasad

Evaluation of programme logistics, assessments of immunization supply chain and development of plans for system strengthening

Independent consultant

38

Diana Rivington

Gender equality, human rights, children’s rights

Senior Fellow in the Faculty of Social Sciences at the University of Ottawa, Canada

39

Gayane Sahakyan

Epidemiology, immunisation services

National Immunisation Program Manager, Republic of Armenia

40

Malek Sbih

Cold chain and logistics

Independent consultant

41

Benjamin Schwartz

Maternal and child health, nutrition, sexual and reproductive health, HIV/AIDS and other infectious diseases

Senior Director, Health Programs, CARE USA

42

Mario Stassen

Design of development strategies, risk management and patient safety

Lecturer at Faculty of Science, Department of Biopharmacy at University of Utrecht; Board member of the Edufarma Foundation

43

Ousmane Amadou Sy

Financial management systems for health

Independent consultant

44

Stephanie Tache

Healthcare systems strengthening, primary health care workforce organisation, medical care for marginalised populations

Independent Consultant

45

Michael Thiede

Health economics, health policy and health systems, procurement and logistics

Managing Director of the Scenarium Group GmbH

46

Asnakew Tsega

Public health, Epidemiology, program management, monitoring and evaluation

Immunisation senior technical officer at USAID funded Maternal and Child Survival Program (MCSP)

47

Charles Shey Umaru Wiysonge

Vaccinology, systematic reviews, programme management

Full Professor and Deputy Director in the Centre for Evidence-based Health Care, Stellenbosch University, South Africa

48

Beena Varghese

Costing and evaluation of MNCH interventions; analysis of health system level issues in MNCH

Senior Health Economist at the Public Health Foundation of India (PHFI) and Adjunct Professor at the St. Johns Research Institute in Bangalore

49

Abdul Wali

Policy and strategy development, health information management, assessments, health system strengthening, immunization

Director of a leading Afghan NGO involved in research, monitoring and evaluation

50

Prashant Yadav

Supply chain management; cold chain logistics

Director of Healthcare Delivery Research at the University of Michigan’s William Davidson Institute and faculty member at the Ross School of Business and the School of Public Health at the University of Michigan

51

Shamsa Zafar

MNCH, Gender

Head of Department, Centre of Excellence in MNCH at the Health Services Academy, Pakistan

close icon

modal window here